Case Reports in Medicine

Copyright © 2012 Danica Maria Vodopivec et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. R. Larson and C. H. Pui, “Tumor lysis syndrome,” 2011, http://www.uptodate.com/contents/tumor-lysis-syndrome?source=search_result&search=tumor+lysis+syndrome&selectedTitle=1~58.
2. S. C. Howard, D. P. Jones, and C. H. Pui, “The tumor lysis syndrome,” New England Journal of Medicine, vol. 364, no. 19, pp. 1844–1854, 2011. View at Publisher · View at Google Scholar · View at Scopus
3. C. Gemici, “Tumour lysis syndrome in solid tumours,” Clinical Oncology, vol. 18, no. 10, pp. 773–780, 2006. View at Publisher · View at Google Scholar · View at Scopus
4. M. S. Cairo and M. Bishop, “Tumour lysis syndrome: new therapeutic strategies and classification,” British Journal of Haematology, vol. 127, no. 1, pp. 3–11, 2004. View at Publisher · View at Google Scholar · View at Scopus
5. M. B. Davidson, S. Thakkar, J. K. Hix, N. D. Bhandarkar, A. Wong, and M. J. Schreiber, “Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome,” American Journal of Medicine, vol. 116, no. 8, pp. 546–554, 2004. View at Publisher · View at Google Scholar · View at Scopus
6. T. I. Mughal, A. A. Ejaz, J. R. Foringer, and B. Coiffier, “An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome,” Cancer Treatment Reviews, vol. 36, no. 2, pp. 164–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
7. B. Coiffier, A. Altman, C. H. Pui, A. Younes, and M. S. Cairo, “Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review,” Journal of Clinical Oncology, vol. 26, no. 16, pp. 2767–2778, 2008. View at Publisher · View at Google Scholar · View at Scopus
8. B. Coiffier, “Acute tumor lysis syndrome—a rare complication in the treatment of solid tumors,” Onkologie, vol. 33, no. 10, pp. 498–499, 2010. View at Publisher · View at Google Scholar · View at Scopus
9. B. Jallad, T. Hamdi, S. Latta, M. N. Alhosaini, F. Kheir, and N. Iroegbu, “Tumor lysis syndrome in small cell lung cancer: a case report and review of the literature,” Onkologie, vol. 34, no. 3, pp. 129–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
10. C. Shenoy, “Acute spontaneous tumor lysis syndrome in a patient with squamous cell carcinoma of the lung,” QJM, vol. 102, no. 1, pp. 71–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
11. M. Abboud and A. Shamseddine, “Maxillary sinus squamous cell carcinoma presenting with fatal tumor lysis syndrome: a case report and review of the literature,” Case Reports in Oncology, vol. 2, pp. 229–233, 2009. View at Google Scholar
12. J. Feld, H. Mehta, and R. L. Burkes, “Acute spontaneous tumor lysis syndrome in adenocarcinoma of the lung: a case report,” American Journal of Clinical Oncology, vol. 23, no. 5, pp. 491–493, 2000. View at Publisher · View at Google Scholar · View at Scopus
13. D. R. Crittenden and G. L. Ackerman, “Hyperuricemic acute renal failure in disseminated carcinoma,” Archives of Internal Medicine, vol. 137, no. 1, pp. 97–99, 1977. View at Publisher · View at Google Scholar · View at Scopus
14. I. S. Woo, J. S. Kim, M. J. Park et al., “Spontaneous acute tumor lysis syndrome with advanced gastric cancer,” Journal of Korean Medical Science, vol. 16, no. 1, pp. 115–118, 2001. View at Google Scholar · View at Scopus
15. E. Vaisban, A. Braester, O. Mosenzon, M. Kolin, and Y. Horn, “Spontaneous tumor lysis syndrome in solid tumors: really a rare condition?” American Journal of the Medical Sciences, vol. 325, no. 1, pp. 38–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
16. N. T. Sklarin and M. Markham, “Spontaneous recurrent tumor lysis syndrome in breast cancer,” American Journal of Clinical Oncology, vol. 18, no. 1, pp. 71–73, 1995. View at Google Scholar · View at Scopus
17. G. Pentheroudakis, V. O'Neill, P. Vasey, and S. Kaye, “Spontaneous acute tumour lysis syndrome in patients with metastatic germ cell tumours: report of two cases,” Supportive Care in Cancer, vol. 9, no. 7, pp. 554–557, 2001. View at Publisher · View at Google Scholar · View at Scopus
18. V. D'Alessandro, A. Greco, C. Clemente et al., “Severe spontaneous acute tumor lysis syndrome and hypoglycemia in patient with germ cell tumor,” Tumori, vol. 96, no. 6, pp. 1040–1043, 2010. View at Google Scholar · View at Scopus
19. E. Bien, L. MacIejka-Kapuscinska, M. Niedzwiecki et al., “Childhood rhabdomyosarcoma metastatic to bone marrow presenting with disseminated intravascular coagulation and acute tumour lysis syndrome: review of the literature apropos of two cases,” Clinical and Experimental Metastasis, vol. 27, no. 6, pp. 399–407, 2010. View at Publisher · View at Google Scholar · View at Scopus
20. N. J. Vogelzang, R. A. Nelimark, and K. A. Nath, “Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma,” Journal of the American Medical Association, vol. 249, no. 4, pp. 513–514, 1983. View at Publisher · View at Google Scholar · View at Scopus
21. M. A. Baumann, J. C. Frick, P. Y. Holoye, and N. J. Vogelzang, “The tumor lysis syndrome,” Journal of the American Medical Association, vol. 250, no. 5, p. 615, 1983. View at Publisher · View at Google Scholar · View at Scopus
22. N. Heching and P. Bonomi, “Tumor lysis syndrome in metastatic small cell cancer,” Proceedings of the American Association for Cancer Research, vol. 29, p. 179, 1988. View at Google Scholar
23. A. M. Hussein and L. G. Feun, “Tumor lysis syndrome after induction chemotherapy in small-cell lung carcinoma,” American Journal of Clinical Oncology, vol. 13, no. 1, pp. 10–13, 1990. View at Google Scholar · View at Scopus
24. L. Y. Dirix, A. Prove, D. Becquart, E. Wouters, P. Vermeulen, and A. Van Oosterom, “Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma,” Cancer, vol. 67, no. 8, pp. 2207–2210, 1991. View at Google Scholar · View at Scopus
25. T. Ohnishi, K. Mori et al., “Tumor lysis syndrome in widely metastasic small-cell lung cancer,” International Journal of Clinical Oncology, vol. 2, pp. 235–237, 1997. View at Google Scholar
26. G. P. Kalemkerian, B. Darwish, and M. L. Varterasian, “Tumor lysis syndrome in small cell carcinoma and other solid tumors,” American Journal of Medicine, vol. 103, no. 5, pp. 363–367, 1997. View at Publisher · View at Google Scholar · View at Scopus
27. M. A. Marinella, “Fatal tumor lysis syndrome and gastric hemorrhage associated with metastatic small-cell lung carcinoma,” Medical and Pediatric Oncology, vol. 32, pp. 464–465, 1999. View at Google Scholar
28. A. M. Kallab and A. P. Jillella, “Tumor lysis syndrome in small cell lung cancer,” Medical Oncology, vol. 18, no. 2, pp. 149–151, 2001. View at Publisher · View at Google Scholar · View at Scopus
29. S. Beriwal, S. Singh, and J. A. Garcia-Young, “Tumor lysis syndrome in extensive-stage small-cell lung cancer,” American Journal of Clinical Oncology, vol. 25, no. 5, pp. 474–475, 2002. View at Publisher · View at Google Scholar · View at Scopus
30. F. E. Mott, A. Esana et al., “Tumor lysis syndrome in solid tumors,” Supportive Cancer Therapy, vol. 2, pp. 188–191, 2005. View at Google Scholar
31. D. A. Persons, J. Garst, R. Vollmer, and J. Crawford, “Tumor lysis syndrome and acute renal failure after treatment of non- small-cell lung carcinoma with combination irinotecan and cisplatin,” American Journal of Clinical Oncology, vol. 21, no. 4, pp. 426–429, 1998. View at Publisher · View at Google Scholar · View at Scopus
32. M. Kurt, I. K. Onal, T. Elkiran, B. Altun, K. Altundag, and I. Gullu, “Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma,” Medical Oncology, vol. 22, no. 2, pp. 203–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
33. D. Ajzensztejn, V. S. Hegde, and M. L. Siow, “Tumor lysis syndrome after treatment with docetaxel for non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 24, no. 15, pp. 2389–2391, 2006. View at Publisher · View at Google Scholar · View at Scopus
34. H. H. Sewani and J. T. Rabatin, “Acute tumor lysis syndrome in a patient with mixed small cell and non-small cell tumor,” Mayo Clinic Proceedings, vol. 77, no. 7, pp. 722–728, 2002. View at Google Scholar · View at Scopus
35. P. J. Saylor and T. R. Reid, “Tumor lysis syndrome after treatment of a gastrointestinal stromal tumor with the oral tyrosine kinase inhibitor sunitinib,” Journal of Clinical Oncology, vol. 25, no. 23, pp. 3544–3546, 2007. View at Publisher · View at Google Scholar · View at Scopus
36. E. M. Pinder, G. S. S. Atwal, A. A. Ayantunde et al., “Tumour lysis syndrome occurring in a patient with metastatic gastrointestinal stromal tumour treated with glivec (imatinib mesylate, gleevec, STI571),” Sarcoma, vol. 2007, Article ID 82012, 2007. View at Publisher · View at Google Scholar · View at Scopus
37. H. S. Han, R. P. Sook, Y. K. Sun et al., “Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer,” Journal of Clinical Oncology, vol. 26, no. 6, pp. 1006–1008, 2008. View at Publisher · View at Google Scholar · View at Scopus
38. M. Boisseau, R. Bugat, and M. Mahjoubi, “Rapid tumour lysis syndrome in a metastatic colorectal cancer increased by treatment with irinotecan (CPT-11),” European Journal of Cancer, vol. 32, no. 4, pp. 737–738, 1996. View at Google Scholar · View at Scopus
39. Z. Nikolic-Tomasevic, S. Jelic, I. Popov, and D. Radosavljevic, “Irinotecan as second-line treatment in metastatic colorectal cancer: dilemmas regarding patient selection and toxicity prediction,” Journal of Chemotherapy, vol. 12, no. 3, pp. 244–251, 2000. View at Google Scholar · View at Scopus
40. I. Oztop, B. Demirkan, A. Yaren et al., “Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan,” Tumori, vol. 90, no. 5, pp. 514–516, 2004. View at Google Scholar · View at Scopus
41. G. Krishnan, K. D'Silva, and A. Al-Janadi, “Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma,” Journal of Clinical Oncology, vol. 26, no. 14, pp. 2406–2408, 2008. View at Publisher · View at Google Scholar · View at Scopus
42. M. Hentrich, X. Schiel et al., “Fatal tumor lysis syndrome after irinotecan/5-FU/folinic acid/bevacizumab-containig therapy in a patient heavily pretrated for metastasic colon cancer,” Acta Oncologica, vol. 47, pp. 155–156, 2008. View at Google Scholar
43. T. E. Lobe, M. S. Karkera, M. D. Custer, R. E. Shenefelt, and E. C. Douglass, “Fatal refractory hyperkalemia due to tumor lysis during primary resection for hepatoblastoma,” Journal of Pediatric Surgery, vol. 25, no. 2, pp. 249–250, 1990. View at Publisher · View at Google Scholar · View at Scopus
44. R. S. Bercovitz, B. S. Greffe, and S. P. Hunger, “Acute tumor lysis syndrome in a 7-month-old with hepatoblastoma,” Current Opinion in Pediatrics, vol. 22, no. 1, pp. 113–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
45. I. A. Burney, “Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma,” Southern Medical Journal, vol. 91, no. 5, pp. 467–470, 1998. View at Google Scholar · View at Scopus
46. S. G. Lehner, J. E. Gould, W. E. A. Saad, and D. B. Brown, “Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma,” American Journal of Roentgenology, vol. 185, no. 5, pp. 1307–1309, 2005. View at Publisher · View at Google Scholar · View at Scopus
47. C. C. Lee, Y. H. Wu, S. H. Chung, and W. J. Chen, “Acute tumor lysis syndrome after thalidomide therapy in advanced hepatocellular carcinoma,” Oncologist, vol. 11, no. 1, pp. 87–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
48. N. Sakamoto, S. Monzawa, H. Nagano et al., “Acute tumor lysis syndrome caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma,” Cardiovascular and Interventional Radiology, vol. 30, pp. 508–511, 2007. View at Google Scholar
49. H. Shiba, Y. Ishida, S. Wakiyama, T. Sakamoto, T. Misawa, and K. Yanaga, “Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma,” Cancer Science, vol. 99, no. 10, pp. 2104–2105, 2008. View at Publisher · View at Google Scholar · View at Scopus
50. P. M. Hsieh, K. C. Hung, and Y. S. Chen, “Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: case reports and literature review,” World Journal of Gastroenterology, vol. 15, no. 37, pp. 4726–4728, 2009. View at Publisher · View at Google Scholar · View at Scopus
51. W. S. Huang and C. H. Yang, “Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient,” World Journal of Gastroenterology, vol. 15, no. 35, pp. 4464–4466, 2009. View at Publisher · View at Google Scholar · View at Scopus
52. K. Shiozawa, M. Watanabe, H. Takenaka et al., “Tumor lysis syndrome after sorafenib for hepatocellular carcinoma: a case report,” Hepato-Gastroenterology, vol. 57, no. 101, pp. 688–690, 2010. View at Google Scholar · View at Scopus
53. S. Joshita, K. Yoshizawa, K. Sano et al., “A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome,” Internal Medicine, vol. 49, no. 11, pp. 991–994, 2010. View at Publisher · View at Google Scholar · View at Scopus
54. T. Nicholaou, R. Wong, and I. D. Davis, “Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate,” Lancet, vol. 369, no. 9577, pp. 1923–1924, 2007. View at Publisher · View at Google Scholar · View at Scopus
55. J. Michels, N. Lassau, M. Gross-Goupil, C. Massard, A. Mejean, and B. Escudier, “Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma,” Investigational New Drugs, vol. 28, no. 5, pp. 690–693, 2010. View at Publisher · View at Google Scholar · View at Scopus
56. E. Rodriguez-Reimundes, F. Perazzo, and A. R. Vilches, “Tumor lysis syndrome in a patient with a renal carcinoma treated with sunitinib,” Medicina, vol. 71, no. 2, pp. 158–160, 2011. View at Google Scholar · View at Scopus
57. C. J. Lin, K. H. Lim, Y. C. Cheng, H. H. Chen, and C. J. Wu, “Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma,” Medical Oncology, vol. 24, no. 4, pp. 455–457, 2007. View at Publisher · View at Google Scholar · View at Scopus
58. S. M. Sorscher, “Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer,” Cancer Chemotherapy and Pharmacology, vol. 54, pp. 191–192, 2004. View at Google Scholar
59. T. Tanvetyanon and A. M. Choudhury, “Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade,” Journal of Urology, vol. 171, no. 4, p. 1627, 2004. View at Publisher · View at Google Scholar · View at Scopus
60. J. L. Wright, D. W. Lin, P. Dewan, and R. B. Montgomery, “Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer,” International Journal of Urology, vol. 12, no. 11, pp. 1012–1013, 2005. View at Publisher · View at Google Scholar · View at Scopus
61. C. J. Lin, R. K. Hsieh, K. H. Lim, H. H. Chen, Y. C. Cheng, and C. J. Wu, “Fatal spontaneous tumor lysis syndrome in a patient with metastatic, androgen-independent prostate cancer,” Southern Medical Journal, vol. 100, no. 9, pp. 916–917, 2007. View at Publisher · View at Google Scholar · View at Scopus
62. P. Cech, J. B. Block, L. A. Cone, and R. Stone, “Tumor lysis syndrome after tamoxifen flare,” New England Journal of Medicine, vol. 315, no. 4, pp. 263–264, 1986. View at Google Scholar · View at Scopus
63. M. E. Stark, M. C. D. Dyer, and C. J. Coonley, “Fatal acute tumor lysis syndrome with metastatic breast carcinoma,” Cancer, vol. 60, no. 4, pp. 762–764, 1987. View at Google Scholar · View at Scopus
64. J. C. Barton, “Tumor lysis syndrome in nonhematopoietic neoplasms,” Cancer, vol. 64, no. 3, pp. 738–740, 1989. View at Google Scholar · View at Scopus
65. P. Drakos, J. Bar-Ziv, and R. Catane, “Tumor lysis syndrome in nonhematologic malignancies: report of a case and review of the literature,” American Journal of Clinical Oncology, vol. 17, no. 6, pp. 502–505, 1994. View at Google Scholar · View at Scopus
66. Y. Ustundag, S. Boyacioglu, I. C. Haznedaroglu, and E. Baltali, “Acute tumor lysis syndrome associated with paclitaxel,” Annals of Pharmacotherapy, vol. 31, no. 12, pp. 1548–1549, 1997. View at Google Scholar · View at Scopus
67. A. Y. Rostom, G. El-Hussainy, A. Kandil, and A. Allam, “Tumor lysis syndrome following hemi-body irradiation for metastatic breast cancer,” Annals of Oncology, vol. 11, no. 10, pp. 1349–1351, 2000. View at Publisher · View at Google Scholar · View at Scopus
68. K. Mevlüt, E. Orhan, E. Huseyin, and G. Nilufer, “Tumor lysis syndrome following a single dose of capecitabine,” The Annals of Pharmacotherapy, vol. 38, article 902, 2004. View at Google Scholar
69. S. F. A. Bilgrami and B. G. Fallon, “Tumor lysis syndrome after combination chemotherapy for ovarian cancer,” Medical and Pediatric Oncology, vol. 21, no. 7, pp. 521–524, 1993. View at Google Scholar · View at Scopus
70. J. K. Chan, S. S. Lin, D. S. McMeekin, and M. L. Berman, “Patients with malignancy requiring urgent therapy: case 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancer,” Journal of Clinical Oncology, vol. 23, no. 27, pp. 6794–6795, 2005. View at Publisher · View at Google Scholar · View at Scopus
71. H. Godoy, J. P. Kesterson, and S. Lele, “Tumor lysis syndrome associated with carboplatin and paclitaxel in a woman with recurrent endometrial cancer,” International Journal of Gynecology and Obstetrics, vol. 109, no. 3, p. 254, 2010. View at Publisher · View at Google Scholar · View at Scopus
72. A. I. Shamseddine, A. M. Khalil, and M. H. Wehbeh, “Acute tumor lysis syndrome with squamous cell carcinoma of the vulva,” Gynecologic Oncology, vol. 51, no. 2, pp. 258–260, 1993. View at Publisher · View at Google Scholar · View at Scopus
73. A. Khalil, M. Chammas, A. Shamseddine, and M. Seoud, “Fatal acute tumor lysis syndrome following treatment of vulvar carcinoma: case report,” European Journal of Gynaecological Oncology, vol. 19, no. 4, pp. 415–416, 1998. View at Google Scholar · View at Scopus
74. K. Yokoi, N. Miyazawa, Y. Kano et al., “Tumor lysis syndrome in invasive thymoma with peripheral blood T-cell lymphocytosis,” American Journal of Clinical Oncology, vol. 20, no. 1, pp. 86–89, 1997. View at Publisher · View at Google Scholar · View at Scopus
75. A. D. Trobaugh-Lotrario, X. Liang, J. S. Janik, M. A. Lovell, and L. F. Odom, “Difficult diagnostic and therapeutic cases: case 2. thymoma and tumor lysis syndrome in an adolescent,” Journal of Clinical Oncology, vol. 22, no. 5, pp. 955–957, 2004. View at Google Scholar · View at Scopus
76. L. M. Minasian, T. P. Szatrowski, M. Rosenblum et al., “Hemorrhagic tumor necrosis during a pilot trial of tumor necrosis factor- α and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanoma,” Blood, vol. 83, no. 1, pp. 56–64, 1994. View at Google Scholar · View at Scopus
77. M. P. Castro, J. VanAuken, P. Spencer-Cisek, S. Legha, and R. W. Sponzo, “Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: a case report and review of the literature,” Cancer, vol. 85, pp. 1055–1059, 1999. View at Google Scholar
78. J. Stoves, D. Richardson, and H. Patel, “Tumour lysis syndrome in a patient with metastatic melanoma treated with biochemotherapy,” Nephrology Dialysis Transplantation, vol. 16, no. 1, pp. 188–189, 2001. View at Google Scholar · View at Scopus
79. G. S. Habib and W. R. Saliba, “Tumor lysis syndrome after hydrocortisone treatment in metastatic melanoma: a case report and review of the literature,” American Journal of the Medical Sciences, vol. 323, no. 3, pp. 155–157, 2002. View at Google Scholar · View at Scopus
80. K. J. Busam, J. Wolchok, A. A. Jungbluth, and P. Chapman, “Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma,” Journal of Cutaneous Pathology, vol. 31, no. 3, pp. 274–280, 2004. View at Publisher · View at Google Scholar · View at Scopus
81. Y. Nakamura, Y. Nakamura, E. Hori et al., “Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma,” International Journal of Dermatology, vol. 48, no. 7, pp. 763–767, 2009. View at Publisher · View at Google Scholar · View at Scopus
82. E. Borne, R. Serafi, F. Piette, and L. Mortier, “Tumour lysis syndrome induced by corticosteroid in metastatic melanoma presenting with initial hyperkalemia,” Journal of the European Academy of Dermatology and Venereology, vol. 23, no. 7, pp. 855–856, 2009. View at Publisher · View at Google Scholar · View at Scopus
83. S. Schuman, J. M. Pearson, J. A. Lucci, and L. B. Twiggs, “Metastatic gestational trophoblastic neoplasia complicated by tumor lysis syndrome, heart failure, and thyrotoxicosis: a case report,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 55, no. 10, pp. 441–444, 2010. View at Google Scholar · View at Scopus
84. C. D. Blanke, M. P. A. Hemmer, and R. S. Witte, “Acute tumor lysis syndrome with choriocarcinoma,” Southern Medical Journal, vol. 93, no. 9, pp. 916–919, 2000. View at Google Scholar · View at Scopus
85. G. Feres, J. I. Salluh, C. Ferreira, and M. Soares, “Severe acute tumor lysis syndrome in patients with germ-cell tumors,” Indian Journal of Urology, vol. 24, no. 4, pp. 555–557, 2008. View at Publisher · View at Google Scholar · View at Scopus
86. R. D. W. Hain, L. Rayner, S. Weitzman, and A. Lorenzana, “Acute tumour lysis syndrome complicating treatment of stage IVS neuroblastoma in infants under six months old,” Medical and Pediatric Oncology, vol. 23, no. 2, pp. 136–139, 1994. View at Publisher · View at Google Scholar · View at Scopus
87. B. H. Kushner, M. P. LaQuaglia, S. Modak, and N. K. V. Cheung, “Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplification,” Medical and Pediatric Oncology, vol. 41, no. 1, pp. 80–82, 2003. View at Publisher · View at Google Scholar · View at Scopus
88. G. C. Tomlinson and L. A. Solberg, “Acute tumor lysis syndrome with metastatic medulloblastoma. A case report,” Cancer, vol. 53, no. 8, pp. 1783–1785, 1984. View at Google Scholar · View at Scopus
89. L. Baeksgaard and J. B. Sorensen, “Acute tumor lusis syndrome in solid tumors—a case report and review of the literature,” Cancer Chemotherapy and Pharmacology, vol. 51, pp. 187–192, 2003. View at Google Scholar
90. J. E. Gold, S. C. Malamud, F. LaRosa, and M. E. Osband, “Adoptive chemoimmunotherapy using ex vivo activated memory T-cells and cyclophosphamide: tumor lysis syndrome of a metastatic soft tissue sarcoma,” American Journal of Hematology, vol. 44, no. 1, pp. 42–47, 1993. View at Google Scholar · View at Scopus
91. J. Khan and V. A. Broadbent, “Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma,” Pediatric Hematology and Oncology, vol. 10, no. 2, pp. 151–155, 1993. View at Google Scholar · View at Scopus
92. K. Q. Qian, H. Ye, Y. W. Xiao, Y. Y. Bao, and C. J. Qi, “Tumor lysis syndrome associated with chemotherapy in primary retroperitoneal soft tissue sarcoma by ex vivo ATP-based tumor chemo-sensitivity assay (ATP-TCA),” International Journal of General Medicine, vol. 2, pp. 1–4, 2009. View at Google Scholar · View at Scopus
93. Y. Hiraizumi, S. Kamoy, Y. Inde, K. Kurose, Y. Ohaki, and T. Takeshita, “A case of tumor lysis syndrome following chemotherapy for a uterine epithelioid leiomyosarcoma with focal rhabdomyosarcomatous differentiation,” The Journal of Obstetrics and Gynaecology Research, vol. 37, pp. 1–6, 2011. View at Google Scholar
94. A. Will and E. Tholouli, “The clinical management of tumour lysis syndrome in haematological malignancies,” British Journal of Haematology, vol. 154, no. 1, pp. 3–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
95. M. R. Zonfrillo, “Management of pediatric tumor lysis syndrome in the emergency department,” Emergency Medicine Clinics of North America, vol. 27, no. 3, pp. 497–504, 2009. View at Publisher · View at Google Scholar · View at Scopus
96. R. Seth and A. S. Bhat, “Management of common oncologic emergencies,” Indian Journal of Pediatrics, vol. 78, no. 6, pp. 709–717, 2011. View at Publisher · View at Google Scholar · View at Scopus